Hatylas Azevedo Selected Research

ACH-000029

11/2020	Brain-wide mapping of c-fos expression in the single prolonged stress model and the effects of pretreatment with ACH-000029 or prazosin.
1/2020	The serotonergic and alpha-1 adrenergic receptor modulator ACH-000029 ameliorates anxiety-like behavior in a post-traumatic stress disorder model.
12/2019	Preclinical characterization of ACH-000029, a novel anxiolytic compound acting on serotonergic and alpha-adrenergic receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hatylas Azevedo Research Topics

Disease

2	Neoplasms (Cancer) 05/2021 - 01/2017
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 11/2020 - 01/2020
2	Vaccinia 09/2019 - 01/2017
2	Fibrosis (Cirrhosis) 09/2016 - 01/2016
1	Treatment-Resistant Schizophrenia 05/2022
1	Schizophrenia (Dementia Praecox) 05/2022
1	Infections 05/2021
1	Hematuria 05/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 05/2021
1	Body Weight (Weight, Body) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Obesity 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Wounds and Injuries (Trauma) 11/2020
1	Non-Muscle Invasive Bladder Neoplasms 10/2020
1	Anxiety Disorders (Anxiety Disorder) 12/2019
1	Nervous System Diseases (Neurological Disorders) 09/2019
1	Albuminuria 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Inflammation (Inflammations) 09/2016
1	Acute Kidney Injury (Acute Renal Failure) 01/2016

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 05/2021 - 09/2016
3	ACH-000029IBA 11/2020 - 12/2019
2	Biomarkers (Surrogate Marker)IBA 05/2021 - 01/2021
2	Serotonin (5 Hydroxytryptamine)IBA 11/2020 - 01/2020
2	Phosphotransferases (Kinase)IBA 09/2019 - 01/2017
2	Protein Kinases (Protein Kinase)IBA 09/2019 - 01/2017
1	Antipsychotic Agents (Antipsychotics)IBA 05/2022
1	ProteomeIBA 05/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	dapagliflozinIBA 01/2021
1	MelatoninIBA 01/2021
1	MART-1 AntigenIBA 01/2021
1	Glutathione (Reduced Glutathione)IBA 10/2020
1	Coat Protein Complex I (COPI)IBA 10/2020
1	alpha-1 Adrenergic Receptors (alpha 1 Adrenergic Receptor)IBA 01/2020
1	BenzodiazepinesIBA 12/2019
1	Anti-Anxiety Agents (Anxiolytics)IBA 12/2019
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2019
1	pyridineIBA 09/2019
1	CreatinineIBA 01/2017
1	CollagenIBA 09/2016
1	CytokinesIBA 09/2016
1	Cisplatin (Platino)FDA LinkGeneric 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016

Therapy/Procedure

1	Oral Administration 01/2021
1	Therapeutics 01/2021
1	Drug Therapy (Chemotherapy) 11/2020